HUP9600998A3 - Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds. - Google Patents

Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds.

Info

Publication number
HUP9600998A3
HUP9600998A3 HU9600998A HUP9600998A HUP9600998A3 HU P9600998 A3 HUP9600998 A3 HU P9600998A3 HU 9600998 A HU9600998 A HU 9600998A HU P9600998 A HUP9600998 A HU P9600998A HU P9600998 A3 HUP9600998 A3 HU P9600998A3
Authority
HU
Hungary
Prior art keywords
indenoylguanidines
compds
antiarrhythmic
sald
contg
Prior art date
Application number
HU9600998A
Other languages
English (en)
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of HU9600998D0 publication Critical patent/HU9600998D0/hu
Publication of HUP9600998A2 publication Critical patent/HUP9600998A2/hu
Publication of HUP9600998A3 publication Critical patent/HUP9600998A3/hu

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
    • C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
    • C07C279/22—Y being a hydrogen or a carbon atom, e.g. benzoylguanidines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Optical Record Carriers And Manufacture Thereof (AREA)
HU9600998A 1995-04-18 1996-04-17 Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds. HUP9600998A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP95105724 1995-04-18
US08/633,223 US5733934A (en) 1995-04-18 1996-04-16 Antiarrythmic and cardioprotective substituted indenoylguanidines

Publications (3)

Publication Number Publication Date
HU9600998D0 HU9600998D0 (en) 1996-06-28
HUP9600998A2 HUP9600998A2 (en) 1997-01-28
HUP9600998A3 true HUP9600998A3 (en) 1997-11-28

Family

ID=26138562

Family Applications (1)

Application Number Title Priority Date Filing Date
HU9600998A HUP9600998A3 (en) 1995-04-18 1996-04-17 Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds.

Country Status (23)

Country Link
US (1) US5733934A (hu)
EP (1) EP0738712B1 (hu)
JP (1) JPH08291131A (hu)
CN (1) CN1061648C (hu)
AT (1) ATE183498T1 (hu)
AU (1) AU706055B2 (hu)
BR (1) BR9601989A (hu)
CA (1) CA2174406A1 (hu)
CZ (1) CZ291538B6 (hu)
DE (1) DE69603771T2 (hu)
DK (1) DK0738712T3 (hu)
ES (1) ES2135811T3 (hu)
GR (1) GR3031540T3 (hu)
HU (1) HUP9600998A3 (hu)
IL (1) IL117927A (hu)
NO (1) NO305655B1 (hu)
NZ (1) NZ286380A (hu)
PL (1) PL182566B1 (hu)
RU (1) RU2182902C2 (hu)
SI (1) SI0738712T1 (hu)
SK (1) SK282011B6 (hu)
TR (1) TR199600316A1 (hu)
ZA (1) ZA963046B (hu)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002502414A (ja) * 1997-06-02 2002-01-22 藤沢薬品工業株式会社 細胞中のＮａ▲上＋▼／Ｈ▲上＋▼交換の阻害剤としてのグアニジン誘導体
US6160134A (en) * 1997-12-24 2000-12-12 Bristol-Myers Squibb Co. Process for preparing chiral cyclopropane carboxylic acids and acyl guanidines
US6011059A (en) * 1997-12-24 2000-01-04 Bristol-Myers Squibb Company Acyl guanidine sodium/proton exchange inhibitors and method
TW462964B (en) * 1998-05-26 2001-11-11 Sumitomo Pharma Guanidine derivatives for the treatment and prevention of disorders caused by inhibiting hyperactivity of Na/H exchange transport system and process for producing the same
DE19859727A1 (de) 1998-12-23 2000-06-29 Aventis Pharma Gmbh Die Verwendung von Hemmern des Natrium-Wasserstoff-Austauschers zur Herstellung eines Medikaments zur Verhinderung von altersbedingten Organ-Dysfunktionen, altersbedingten Erkrankungen zur Lebensverlängerung
JP2002542291A (ja) 1999-04-23 2002-12-10 ブリストル−マイヤーズ スクイブ カンパニー ジ環式アシルグアニジン・ナトリウム／プロトン交換抑制剤および方法
EP2617709B8 (en) * 2003-06-26 2022-12-21 Biotron Limited Guanidine derivatives as antiviral agents
US20070099968A1 (en) * 2004-06-26 2007-05-03 Biotron Limited Antiviral compounds and methods

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2734904A (en) * 1956-02-14 Xcxnhxc-nh
US3780027A (en) * 1970-04-29 1973-12-18 Merck & Co Inc Anthranilic acid derivatives
US4544670A (en) * 1982-08-24 1985-10-01 William H. Rorer, Inc. Method of treating coccidiosis with acyl guanidines
EP0556673B1 (de) * 1992-02-15 1997-09-17 Hoechst Aktiengesellschaft Ortho-substituierte Benzoylguanidine, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament oder Diagnostikum sowie sie enthaltendes Medikament
DE4326005A1 (de) * 1993-08-03 1995-02-09 Hoechst Ag Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament
EP0639573A1 (de) * 1993-08-03 1995-02-22 Hoechst Aktiengesellschaft Benzokondensierte 5-Ringheterocyclen, Verfahren zu ihrer Herstellung, ihre Verwendung als Medikament, ihre Verwendung als Diagnostikum, sowie sie enthaltendes Medikament

Also Published As

Publication number Publication date
MX9601424A (es) 1997-07-31
CA2174406A1 (en) 1996-10-19
HUP9600998A2 (en) 1997-01-28
ZA963046B (en) 1996-10-22
HU9600998D0 (en) 1996-06-28
GR3031540T3 (en) 2000-01-31
BR9601989A (pt) 1998-04-07
CZ291538B6 (cs) 2003-03-12
IL117927A (en) 2001-12-23
SK48396A3 (en) 1996-12-04
AU5067696A (en) 1996-10-31
ES2135811T3 (es) 1999-11-01
DE69603771D1 (de) 1999-09-23
CZ109696A3 (en) 1996-11-13
IL117927A0 (en) 1996-08-04
TR199600316A1 (tr) 1997-03-21
NO961521D0 (no) 1996-04-17
SI0738712T1 (en) 1999-12-31
NZ286380A (en) 1997-09-22
PL182566B1 (pl) 2002-01-31
CN1061648C (zh) 2001-02-07
AU706055B2 (en) 1999-06-10
EP0738712A1 (en) 1996-10-23
CN1140164A (zh) 1997-01-15
DE69603771T2 (de) 2000-09-07
SK282011B6 (sk) 2001-10-08
RU2182902C2 (ru) 2002-05-27
ATE183498T1 (de) 1999-09-15
NO305655B1 (no) 1999-07-05
NO961521L (no) 1996-10-21
US5733934A (en) 1998-03-31
DK0738712T3 (da) 2000-03-06
JPH08291131A (ja) 1996-11-05
EP0738712B1 (en) 1999-08-18

Similar Documents

Publication Publication Date Title
HUP9602745A2 (en) Anticelladhesive piperidine- und pyrrolidine-carbonacids, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
EP0613873A3 (en) Oligomerization process.
EP0599159A3 (de) a-L-Rhamnosidase zur Gewinnung von Rhamnose, ein Verfahren zur Herstellung und ihre Verwendung.
EP0684148A3 (en) Shaped and decorated product.
HUP9900621A3 (en) 3,4-disubstituted phenylethanolaminotetralincarboxamide derivatives, process to prepare them and pharmaceuticals contg. the said compds.
AU1724595A (en) Process for preparing retort-stable, shaped food pieces
HK1010885A1 (en) 10,13,15-trioxatricyclo [9.2.1.1.9.6]-pentadecanone-derivatives, process for their preparation and pharmaceutical containing them
HUP9600998A3 (en) Antiarrhythmic and cardioprotective substituted indenoylguanidines, pharmaceutical compns. contg. them and process for preparing the sald compds.
HUP9602262A2 (en) Prostaglandin derivatives, pharmaceutical compns. contg. them and process for preparing the said compds.
EP0622369A3 (de) 2-Amino-4-chinolin-dihydropyridine, Verfahren zu ihrer Herstellung und ihre Verwendung.
GR3021203T3 (en) Process for the preparation of 1,1,1,2-tetrafluoro-2-chloroethan and pentafluorethane.
EP0659806A3 (de) Präkeramische Polyborosilazane, Verfahren zu deren Herstellung sowie daraus erhältliches keramisches Material.
EP0670912A4 (en) LIGHTWEIGHT AND HIGH RESISTANCE BERYLLIUM-ALUMINUM ALLOY.
HUP9601305A2 (en) Fluorine-containing benzoyl-guanidine derivatives, pharmaceutical compns. contg. them, process for preparing the said compds. and the use of the compds.
EP0684271A3 (de) Verfahren zur Herstellung von Polyamiden auf Basis von alpha,w-Dinitrilen.
HUP9700747A1 (en) Novel retinoids, pharmaceutical compns. contg. them and process for preparing the said compds.
HUT71793A (en) 2,4-diamino-3-hydroxy-carboxylic acid derivatives, pharmaceutical compns. contg. them and process for producing the said compds.
HUT77004A (hu) Antiaritmiás szerekként felhasználható nitro-benzamidok, előállításuk és ezeket tartalmazó gyógyszerkészítmények
EP0637465A3 (en) Process for the separation of food products.
HUP9802316A3 (en) Didepsipeptide-based endoparasiticides, new didepsipeptides and process for preparing the same
HUP9602331A2 (en) Alkenyl-benzoyl-guanidine derivatives, pharmaceutical compns. contg. the said compds., process for preparing them and the use of the compds.
HUT69285A (en) Ethanolamine derivatives, pharmaceutical compns. contg. them and process to prepare the sald compds.
PH31154A (en) Process for preparing 1-alkylryl-2-alkyl-5-formyl-imidazole.
HUP9601701A2 (en) Aromatic hydroxamic acid compounds, process for producing them and their use pharmaceutical compns. contg. them and process for producing the said compds.
EP0593058A3 (en) Surface-active peptides, processes for their preparation and microorganisms producing them.